Callahan Advisors LLC Trims Position in Cardinal Health, Inc. $CAH

Callahan Advisors LLC trimmed its holdings in Cardinal Health, Inc. (NYSE:CAHFree Report) by 23.1% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 33,333 shares of the company’s stock after selling 10,017 shares during the period. Callahan Advisors LLC’s holdings in Cardinal Health were worth $6,850,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Strategy Asset Managers LLC purchased a new stake in shares of Cardinal Health in the third quarter valued at about $775,000. Mirae Asset Global Investments Co. Ltd. raised its holdings in Cardinal Health by 15.3% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 37,833 shares of the company’s stock worth $5,938,000 after purchasing an additional 5,030 shares in the last quarter. Versor Investments LP purchased a new position in Cardinal Health during the third quarter worth about $2,090,000. Atle Fund Management AB raised its holdings in Cardinal Health by 13.1% during the third quarter. Atle Fund Management AB now owns 30,297 shares of the company’s stock worth $4,755,000 after purchasing an additional 3,500 shares in the last quarter. Finally, Machina Capital S.A.S. raised its holdings in Cardinal Health by 248.0% during the third quarter. Machina Capital S.A.S. now owns 27,054 shares of the company’s stock worth $4,246,000 after purchasing an additional 19,280 shares in the last quarter. 87.17% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the stock. TD Cowen increased their price target on shares of Cardinal Health from $251.00 to $255.00 and gave the stock a “buy” rating in a report on Friday, May 1st. Mizuho increased their price target on shares of Cardinal Health from $222.00 to $235.00 and gave the stock an “outperform” rating in a report on Friday, February 6th. JPMorgan Chase & Co. cut their price target on shares of Cardinal Health from $243.00 to $215.00 and set a “neutral” rating for the company in a report on Monday, May 4th. William Blair assumed coverage on shares of Cardinal Health in a report on Tuesday, April 28th. They set an “outperform” rating for the company. Finally, Citigroup cut their price target on shares of Cardinal Health from $249.00 to $245.00 and set a “buy” rating for the company in a report on Friday, May 1st. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Cardinal Health has a consensus rating of “Moderate Buy” and an average price target of $241.80.

Read Our Latest Analysis on CAH

Cardinal Health Price Performance

CAH stock opened at $199.32 on Thursday. The company’s 50 day simple moving average is $205.83 and its 200-day simple moving average is $208.68. The firm has a market capitalization of $46.68 billion, a PE ratio of 30.48, a P/E/G ratio of 1.19 and a beta of 0.53. Cardinal Health, Inc. has a 12 month low of $137.75 and a 12 month high of $233.60.

Cardinal Health (NYSE:CAHGet Free Report) last released its quarterly earnings results on Thursday, April 30th. The company reported $3.17 EPS for the quarter, beating the consensus estimate of $2.79 by $0.38. The business had revenue of $60.94 billion for the quarter, compared to analyst estimates of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The company’s quarterly revenue was up 11.0% on a year-over-year basis. During the same period in the prior year, the business earned $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, sell-side analysts anticipate that Cardinal Health, Inc. will post 10.76 earnings per share for the current year.

Cardinal Health Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be given a $0.5158 dividend. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 annualized dividend and a dividend yield of 1.0%. The ex-dividend date is Wednesday, July 1st. Cardinal Health’s dividend payout ratio (DPR) is currently 31.19%.

Cardinal Health Company Profile

(Free Report)

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

Featured Articles

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAHFree Report).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.